Qian Y. Yao

Kunming, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Correction: Repurposing cephalosporins as excellent anticancer agents and chemosensitizers for inflammation-driven cancer therapy.

Correction: Repurposing cephalosporins as excellent anticancer agents and chemosensitizers for inflammation-driven cancer therapy.

Journal: Scientific reports
Published: March 27, 2026

The role and clinical value of natriuretic peptide receptor family in malignant tumor.

The role and clinical value of natriuretic peptide receptor family in malignant tumor.

Journal: Cell death discovery
Published: April 06, 2025

Anti-liver cancer therapeutic targets and safety of usenamine A in experimental liver cancer.

Anti-liver cancer therapeutic targets and safety of usenamine A in experimental liver cancer.

Journal: The Journal of pharmacy and pharmacology
Published: December 04, 2023

Combination of Cefotaxime and Cisplatin Specifically and Selectively Enhances Anticancer Efficacy in Nasopharyngeal Carcinoma.

Combination of Cefotaxime and Cisplatin Specifically and Selectively Enhances Anticancer Efficacy in Nasopharyngeal Carcinoma.

Journal: Current cancer drug targets
Published: June 30, 2022

Combination of levofloxacin and cisplatin enhances anticancer efficacy via co-regulation of eight cancer-associated genes.

Combination of levofloxacin and cisplatin enhances anticancer efficacy via co-regulation of eight cancer-associated genes.

Journal: Discover oncology
Published: May 24, 2022

Mechanism of Xiaoying Daotan decoction in treating Hashimoto's thyroiditis based on the Notch/Treg/Th17 pathway.

Mechanism of Xiaoying Daotan decoction in treating Hashimoto's thyroiditis based on the Notch/Treg/Th17 pathway.

Journal: Annals of translational medicine
Published: October 14, 2021

Levofloxacin exerts broad-spectrum anticancer activity via regulation of THBS1, LAPTM5, SRD5A3, MFAP5 and P4HA1.

Levofloxacin exerts broad-spectrum anticancer activity via regulation of THBS1, LAPTM5, SRD5A3, MFAP5 and P4HA1.

Journal: Anti-cancer drugs
Published: August 22, 2021

Inhibitory Effect of Astragalus Polysaccharide Combined with Cisplatin on Cell Cycle and Migration of Nasopharyngeal Carcinoma Cell Lines.

Inhibitory Effect of Astragalus Polysaccharide Combined with Cisplatin on Cell Cycle and Migration of Nasopharyngeal Carcinoma Cell Lines.

Journal: Biological & pharmaceutical bulletin
Published: May 06, 2021

Cephalosporin antibiotics specifically and selectively target nasopharyngeal carcinoma through HMOX1-induced ferroptosis.

Cephalosporin antibiotics specifically and selectively target nasopharyngeal carcinoma through HMOX1-induced ferroptosis.

Journal: Life sciences
Published: January 09, 2021

Effects and mechanism of microRNA‑218 against lung cancer.

Effects and mechanism of microRNA‑218 against lung cancer.

Journal: Molecular medicine reports
Published: September 30, 2019

Hepatitis B virus X protein promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cell line HCCLM3 by targeting HMGA2.

Hepatitis B virus X protein promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cell line HCCLM3 by targeting HMGA2.

Journal: Oncology letters
Published: October 29, 2017

MicroRNA-370 inhibits the growth and metastasis of lung cancer by down-regulating epidermal growth factor receptor expression.

MicroRNA-370 inhibits the growth and metastasis of lung cancer by down-regulating epidermal growth factor receptor expression.

Journal: Oncotarget
Published: December 23, 2016
Showing 1-12 of 17

Last Updated: 09/26/2026